LDL Cholesterol

LDL-cholesterol (low-density lipoprotein cholesterol) is one of the main carriers of cholesterol in the bloodstream. Cholesterol itself is essential: it forms cell membranes, supports hormone production, and enables bile acid synthesis for fat digestion. Because cholesterol is not water-soluble, it travels through the blood packaged inside lipoproteins, with LDL responsible for transporting cholesterol from the liver to tissues throughout the body.

Problems arise not simply from cholesterol intake, but from how LDL particles behave in the body and the metabolic environment they circulate in. When LDL particles persist in the bloodstream for too long — often due to insulin resistance, inflammation, or poor lipid clearance — they are more likely to penetrate the artery wall. Once inside the vessel lining, LDL can become oxidised, triggering an inflammatory response that contributes to plaque formation (atherosclerosis).

Importantly, LDL-cholesterol is not a single uniform substance. LDL particles vary in size and density. Larger, more buoyant LDL particles are generally considered less harmful, while smaller, denser LDL particles are more strongly associated with arterial damage. Diet, particularly carbohydrate quality, sugar intake, inflammation, and metabolic health, strongly influence which LDL pattern predominates.

HDL-cholesterol (“good cholesterol”) plays a complementary role by transporting excess cholesterol away from tissues and back to the liver for recycling or excretion. Cardiovascular risk is therefore shaped not only by LDL quantity, but by lipoprotein balance, particle behaviour, and overall metabolic context.

LDL-cholesterol remains a causal contributor to atherosclerosis and cardiovascular disease, but modern research shows that LDL does not operate in isolation. Cardiovascular risk reflects the interaction between LDL levels, particle characteristics, inflammation, blood sugar regulation, lifestyle factors, and diet quality.

Historically, saturated fat was labelled the primary dietary driver of elevated LDL and heart disease. This view originated largely from early observational research, most notably Ancel Keys’ lipid hypothesis and the Seven Countries Study. Subsequent re-evaluation has revealed that these early conclusions were limited by confounding factors, selective data inclusion, and a failure to account for sugar intake, refined carbohydrates, smoking, and overall dietary patterns.

More recent systematic reviews and meta-analyses—including those published in Annals of Internal Medicine—have found that reducing total saturated fat alone does not clearly reduce cardiovascular events, particularly when saturated fat is replaced with refined carbohydrates or industrial vegetable oils. Importantly, different saturated fatty acids behave differently in the body. For example, stearic acid, found in higher amounts in grass-fed beef and cocoa, does not raise LDL and may even lower it, whereas palmitic and myristic acids can raise LDL in some individuals.

Saturated fat also tends to raise HDL-cholesterol, while high sugar and refined carbohydrate intake lowers HDL and increases triglycerides—changes that promote smaller, more harmful LDL particles. Diets high in added sugars and ultra-processed foods are strongly linked to inflammation, insulin resistance, elevated triglycerides, and adverse LDL particle profiles, all of which amplify cardiovascular risk.

Clinical guidelines still emphasise LDL reduction because lowering LDL consistently reduces cardiovascular events. However, how LDL is lowered matters. Improvements achieved through whole-food diets, fibre intake, physical activity, weight regulation, and sugar reduction are associated with broader metabolic benefits beyond cholesterol alone.

Dietary factors

LDL-cholesterol responds more to diet quality than fat quantity alone. Diets high in refined carbohydrates, added sugars (including high-fructose corn syrup), and ultra-processed foods raise triglycerides, lower HDL, and promote small, dense LDL particles. These changes are strongly linked to cardiovascular risk.

Saturated fat has heterogeneous effects. Saturated fat from whole, minimally processed foods (such as coconut, dairy, and grass-fed meats) does not uniformly worsen cardiovascular risk and may improve HDL and LDL particle size in some individuals. In contrast, saturated fat consumed alongside refined carbohydrates, sugars, and industrial seed oils is more likely to raise LDL in a harmful metabolic context.

LDL is consistently lowered by soluble fibre (oats, legumes, apples, citrus), plant sterols/stanols, nuts, seeds, olive oil, vegetables, and dietary patterns rich in whole foods.

Lifestyle factors

Physical inactivity, excess body weight, smoking, poor sleep, and chronic stress impair lipid metabolism and LDL clearance. Regular exercise improves LDL turnover and particle profile. Weight loss of 5–10% improves LDL, triglycerides, and HDL simultaneously.

Related biomarkers and conditions

Insulin resistance, elevated triglycerides, low HDL, thyroid dysfunction, and chronic inflammation worsen LDL behaviour. LDL should always be interpreted alongside HDL, triglycerides, and overall metabolic health rather than as a standalone value.

Micronutrients and supplements

Plant sterols/stanols (~2 g/day), soluble fibres such as psyllium, and red yeast rice have demonstrated LDL-lowering effects. Omega-3 fatty acids primarily reduce triglycerides and indirectly improve LDL particle quality. Supplement use should be individualised and supervised.

If your LDL-C is high

Your results are high, meaning LDL-cholesterol is above the optimal range and long-term cardiovascular risk may be increased.

Diet:

• Focus on reducing added sugars and refined carbohydrates while prioritising whole foods.

• Include 10–25 g of soluble fibre daily from oats, legumes, apples, and citrus.

• Use olive oil, nuts, seeds, and avocado regularly.

• Saturated fat does not need to be universally eliminated; instead, prioritise higher-quality sources (e.g., minimally processed dairy, grass-fed butter and ghee, grass-fed meats) while avoiding ultra-processed foods and trans fats.

• Aim for 2–3 servings of fatty fish weekly.

• Consider foods fortified with plant sterols/stanols (~2 g/day).
  .

Lifestyle:

• Accumulate at least 150 minutes of moderate-intensity exercise per week, such as brisk walking or cycling.

• If overweight, a 5–10% reduction in body weight can meaningfully lower LDL.

• Avoid smoking and keep alcohol intake moderate.

Supplements:
Plant sterols/stanols, psyllium fibre, or red yeast rice may be considered under healthcare supervision, as effectiveness and safety vary between individuals.

Additional tests:

• If LDL is very high or there is a family history of early heart disease

• consider additional risk markers such as lipoprotein(a) and consult with your healthcare provider.
  

If your LDL-C is low:

Your results are low, which is generally protective.

Diet:

• Maintain a balanced diet that includes healthy fats (olive oil, nuts, seeds), lean proteins, and a wide variety of vegetables and fruits.

• Avoid unnecessarily restrictive or very low-fat diets unless medically advised.
  .

Lifestyle:
Continue regular physical activity and healthy weight maintenance.

Additional tests:

• If LDL is extremely low and symptoms are present

• discussion with a healthcare provider may be appropriate

1. Berisha H, Hattab R, Comi L, et al. Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk. Nutrients. 2025;17(5):776.

2. Hunter PM, Hegele RA. Functional Foods and Dietary Supplements for the Management of Dyslipidaemia. Nat Rev Endocrinol. 2017;13(5):278–288.

3. Agarwala A, Petersen KS, Jafari F, Kris-Etherton PM. Dietary Management of Dyslipidemia. Prog Cardiovasc Dis. 2022;75:49–58.

4. Jellinger PS, Handelsman Y, Rosenblit PD, et al. AACE Guidelines for Management of Dyslipidemia. Endocr Pract. 2017;23(Suppl 2):1–87.

5. Baumgartner S, Bruckert E, Gallo A, Plat J. Functional Foods With LDL-Lowering Effects. Atherosclerosis. 2020;311:116–123.

6. Rosa Cde O, et al. Impact of Nutrients on Dyslipidemias. Adv Nutr. 2015;6(6):703–711.

7. Cheung B, et al. Lipid-Lowering Nutraceuticals. J Clin Med. 2023;12(10):3414.

8. Feingold KR, Chait A. Approach to Elevated LDL-Cholesterol. Best Pract Res Clin Endocrinol Metab. 2023;37(3):101658.

9. Berberich AJ, Hegele RA. A Modern Approach to Dyslipidemia. Endocr Rev. 2022;43(4):611–653.

10. Grant JK, et al. Dietary Supplements in Lipid-Lowering. J Lipid Res. 2024;65(2):100493.

11. Penson PE, Banach M. Nutraceuticals for Dyslipidaemias. Nutrients. 2021;13(9):2957.